ENDRA posts updated investor presentation reflecting new business strategy announced March 31, 2025

ENDRA Life Sciences Inc.

Filed under Item 7.01; presentation posted on company website without new financial or operational data.
No new material facts disclosed; presentation references previously announced strategy shift.
Filing contains only procedural language; investor gains no actionable information from this 8-K alone.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.